Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Really?

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Aug 25, 2021 6:00pm

135 Views

Post# 33765311

RE:RE:Really?

What the heck is a DOUBTER ????

jfm1330 wrote: The good news is that few shareholders are willing to sell at the actual price. Thera needs to prove the doubters wrong.

SPCEO1 wrote: So far today THTX has traded an incomprehensiblly small 5,402 shares. How can that even be possible? We have seen the volume dry up in the mornings several times now and it is hard to comprehend how a company with such intriguing prospects could be so hidden from the investing public in the midst of one of the biggest bull markets of all time. Trading volume in the past has recovered over the course of the day, but THTX trading really stands out as a bit bizarre in this regard. The mismatch of the company's exciting prospects and interest in the stock is really impossible to reconcile, especialy given the backdrop of the market.

One result of the lack of trading volume is the bid/ask spread is too wide. So, the stock jumps around quite significantly on tiny volume.